All Episodes
Citeline Podcasts — 625 episodes · page 3 of 7
Scrip's Five Must-Know Things - Nov. 4, 2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Oct. 27, 2025
Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation
Innovating Autoimmune Treatment with In Vivo CAR-T
How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Oct. 20, 2025
Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy
Adalvo: Exploring European B2B Pharma’s Next Steps
Lupus Clinical Development Enters a New Era of Innovation
Essential Pharma – Following A Patient First Philosophy
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
Scrip's Five Must-Know Things - Oct. 14, 2025
Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases
Defining the Next Era of Disruption
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025
Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao
Scrip's Five Must-Know Things - Oct. 6, 2025
Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025
Scrip's Five Must-Know Things - Sept. 30, 2025
The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy
3分で解説 #世界のファーマ】第26回 欧州の先発医薬品 米国関税15％適用へ (Japanese-language podcast) Sept.24, 2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.22, 2025
Scrip's Five Must-Know Things - September 22, 2025
ICROM on Innovation in HPAPI & Crystallization
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.16, 2025
Scrip's Five Must-Know Things - September 16, 2025
Drug Fix: US FDA DTC Ad Crackdown Emerges From MAHA Report
Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech
Why Local Matters: A Leadership Perspective on Community-Based Trials
From Abandonment To Opportunity In Pediatric Pharma
Scrip's Five Must-Know Things - September 5, 2025
Is It Better To Be A Sustainability ‘Shaper’ Or ‘Staller’? With PA Consulting’s Rhea Patten
Drug Fix: US FDA Drops Offit, Others From Adcomms, Releases Unapproved Product Rejection Letters
China Biopharma English-Language Podcast: China Innovative Drugs And Commercial Insurance
Scrip's Five Must-Know Things - Sept. 1, 2025
Drug Fix: US FDA Changes COVID-19 Vaccine Labeling, Reimbursement Confusion Rises
Navigating What’s Next for Global Drug Development: What Sponsors Need to Know
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
【3分で解説 #世界のファーマ】第25回 中国、民間保険で新薬のアクセス拡大へ
How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten
Scrip's Five Must-Know Things - August 25, 2025
Merck KGaA's Vision For Making Digital Health Redundant
Tevard CEO Sees Hope for HIs Daughter In His Company's tRNA Platform
Scrip's Five Must-Know Things - August 15, 2025
Scrip's Five Must-Know Things - August 8, 2025
Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper
Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models
Poolbeg CEO On The Biotech’s Big Bet On Small Molecules
Scrip's Five Must-Know Things - August 4, 2025
Exploring Ex-US Markets to Reduce Risk for Your Clinical Trials
The Patient Journey: Key R&D Considerations In Rheumatoid Arthritis
Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland
Scrip's Five Must-Know Things - July 28, 2025
Drug Fix: US FDA’s New Top Drug Regulator, Sarepta’s Options After Elevidys Stand-Off
MoonLake Leaders On Its Fast-Track Vision And $500m Deal
Scrip's Five Must-Know Things - July 22, 2025
Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’
Drug Fix: CBER Director’s Political Spin On COVID-19 Vaccines And US FDA RIFs Finalized
Strategic Insights into the RNA Market
Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep Tech & FDA Rules
“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision
Astellas Doubles Down on Gene Therapy Despite Industry Headwinds
Scrip's Five Must-Know Things - July 14, 2025
Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette
바이오 USA: 금융 시장 스트레스, 딜메이킹 기회 창출 (Korean-language podcast)
Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines
Acuitas CSO on CRISPR Delivery Breakthrough and Innovations in Lipid Nanoparticles
Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators
How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke
Scrip's Five Must-Know Things - July 7, 2025
【3分で解説 世界のファーマ】第24回 トランプ関税 製薬大国インドへの影響 (Japanese-language podcast)
ADDF's Karen Harris: Investing in Alzheimer's Like a VC
China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss
Datamonitor Healthcare Podcast: ASCO 2025
Master Regulatory Hurdles and Accelerate Your Drug Development
Scrip's Five Must-Know Things - June 30, 2025
Post-BIO Podcast: Thoughts From The Frontlines
Navigating Regulatory Uncertainty: Diversity Action Plans
How to Crush Competitive Threats and Stand Out in Biotech
Scrip's Five Must-Know Things - June 23, 2025
유럽 바이오기업, 자금조달의 현주소는? (Korean-language podcast)
Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients
Unpacking EU Omnibus And Its Impact On Sustainability: With CEN Group’s Jasper Crone
Scrip's Five Must-Know Things - 16 June 2025
Drug Fix: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing
Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)
Strategies to Secure Critical Biotech Funding Amid Market Challenges
How to Survive Innovation Pressure in Today’s Biotech Landscape
Scrip's Five Must-Know Things - 9 June 2025
Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts
A Deep Dive into Sjögren's Disease
Digital Health Roundup: Synchron Syncs With Apple, Ketryx’s AI Agents, AdvaMed’s AI RoadMap